Valuation : Stereotaxis, Inc.

Market Cap 132M 114M 108M 97.91M 183M 12.62B 185M 1.28B 493M 6.42B 497M 486M 20.43B P/E 2026 *
-6.49x
P/E 2027 * -9x
Enterprise Value 132M 114M 108M 97.91M 183M 12.62B 185M 1.28B 493M 6.42B 497M 486M 20.43B EV / Sales 2026 *
3.85x
EV / Sales 2027 * 2.9x
Free-Float
78.85%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week-5.80%
Current month-9.72%
1 month-8.45%
3 months-29.73%
6 months-37.20%
Current year-43.48%
1 week 1.26
Extreme 1.265
1.41
1 month 1.26
Extreme 1.265
1.51
Current year 1.24
Extreme 1.24
2.86
1 year 1.24
Extreme 1.24
3.59
3 years 1.24
Extreme 1.24
3.59
5 years 1.24
Extreme 1.24
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 2017-02-02
Director of Finance/CFO 57 2019-09-30
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 2005-01-31
Chairman - 2017-02-02
Director/Board Member 71 2016-09-28
Date Insider Type Main position Quantity % Market Cap. Importance
7/1/26 Free

Director

43,103 0.0441%
7/1/26 Free

Director

43,103 0.0441%
7/1/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-5.80%-55.02%-23.08% 132M
-0.41%-0.88%+25.03%+16.38% 224B
-2.11%-4.47%+3.19%-19.26% 144B
+2.04%-3.07%-22.90%+20.87% 125B
-4.14%-10.90%-60.13%-19.99% 65.16B
-0.70%-2.64%-18.67%-13.99% 50.05B
+0.68%-4.46%+8.73%+17.15% 49.67B
-1.13%-5.46%+13.36%+25.55% 40.81B
-0.78%-2.56%+33.65%+52.38% 39.77B
-1.82%-5.62%+104.92%+27.10% 30.96B
Average -0.35%-2.65%+3.22%+8.31% 76.93B
Weighted average by Cap. -0.42%-2.29%+5.09%+8.20%

Financials

2026 *2027 *
Net sales 34.33M 29.58M 27.92M 25.41M 47.5M 3.28B 47.95M 332M 128M 1.67B 129M 126M 5.3B 45.67M 39.34M 37.14M 33.8M 63.18M 4.36B 63.78M 442M 170M 2.22B 171M 168M 7.05B
Net income -20.13M -17.34M -16.37M -14.9M -27.86M -1.92B -28.12M -195M -75M -978M -75.6M -73.94M -3.11B -14.77M -12.72M -12.01M -10.93M -20.43M -1.41B -20.63M -143M -55.01M -717M -55.45M -54.23M -2.28B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
26-09-10 US$1.300 -1.52% 625,263
26-09-09 US$1.320 +1.54% 587,314
26-09-08 US$1.300 -6.47% 727,251
26-09-04 US$1.390 0.00% 344,434
26-09-03 US$1.390 +0.72% 399,628
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.320USD
Average target price
3.000USD
Spread / Average Target
+127.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!